Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research published online today led by DTU researchers has found that people may be able to test themselves for diabetes in the comfort of their own home, using a novel electronic screening device.

The study, performed by DTU's NIHR supported Translational Research Group (TRG), is published in the journal Diabetes Care. The TRG tested the device in both healthy volunteers and people with diabetes, both in the home and in the clinic. They found that the device was popular, easy to use, and did not require any special training. This suggests it could be used to help screen people for diabetes in the community.

Nearly three million people have diabetes in the UK, and many more are likely to have the condition but don't know it. "Currently, doctors offer blood test screening to people who are thought to be at high risk of developing diabetes according to established risk factors like age or having a close relative who has diabetes," says Dr Angelyn Bethel, DTU Deputy Director and lead researcher on the study. "But this still requires people to come to a clinic or hospital with laboratory facilities to take the test. This new device would allow the initial screening test to be done at home, and only those most likely to have diabetes or pre-diabetes - the condition that leads to diabetes - would need to see their GP for confirmation."

"People taking part in our trial liked the option to test at home rather than having to go to their doctors' surgery. That added convenience might encourage more people to undergo screening," continues Dr Bethel.

"A device like this has good potential as a research tool to help us find people eligible to take part in diabetes research studies, or could be used in parts of the world where access to laboratory facilities and skilled health care personnel are not available or the tests are too expensive," she continues. "The prototype device tested lacked the necessary accuracy, but once this is corrected, our study shows that home diabetes screening could become a real possibility."

SmartSensor telemed developed the test kit, and the research was funded by Novartis Pharma AG.

To read more about TRG and read the full paper, visit and

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with


Similar stories

RDM researchers awarded Oxford-Bristol Myers Squibb Fellowships

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Six new Oxford-BMS Fellowships for 2021 were announced.

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.

11 RDM researchers awarded Associate Professorships

We are delighted to announce that 11 RDM researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Medical Sciences Division.